These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27317361)

  • 1. Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ?
    Pratt J; Dawson N; Morris BJ; Grent-'t-Jong T; Roux F; Uhlhaas PJ
    Schizophr Res; 2017 Feb; 180():4-12. PubMed ID: 27317361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings.
    Rivolta D; Heidegger T; Scheller B; Sauer A; Schaum M; Birkner K; Singer W; Wibral M; Uhlhaas PJ
    Schizophr Bull; 2015 Sep; 41(5):1105-14. PubMed ID: 25987642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalamocortical oscillations in a genetic model of absence seizures.
    D'Arcangelo G; D'Antuono M; Biagini G; Warren R; Tancredi V; Avoli M
    Eur J Neurosci; 2002 Dec; 16(12):2383-93. PubMed ID: 12492433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
    Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.
    Watis L; Chen SH; Chua HC; Chong SA; Sim K
    J Neural Transm (Vienna); 2008; 115(3):493-511. PubMed ID: 18301955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges.
    Phillips KG; Uhlhaas PJ
    J Psychopharmacol; 2015 Feb; 29(2):155-68. PubMed ID: 25567552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward understanding thalamocortical dysfunction in schizophrenia through computational models of neural circuit dynamics.
    Murray JD; Anticevic A
    Schizophr Res; 2017 Feb; 180():70-77. PubMed ID: 27784534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
    Goff DC; Coyle JT
    Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis.
    Ng WX; Lau IY; Graham S; Sim K
    Neurosci Biobehav Rev; 2009 Mar; 33(3):336-54. PubMed ID: 18955079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.
    Sherif MA; Cortes-Briones JA; Ranganathan M; Skosnik PD
    Eur J Neurosci; 2018 Oct; 48(8):2890-2902. PubMed ID: 29247465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamo-cortical functional connectivity in schizophrenia and bipolar disorder.
    Skåtun KC; Kaufmann T; Brandt CL; Doan NT; Alnæs D; Tønnesen S; Biele G; Vaskinn A; Melle I; Agartz I; Andreassen OA; Westlye LT
    Brain Imaging Behav; 2018 Jun; 12(3):640-652. PubMed ID: 28444556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the thalamus in schizophrenia from a neuroimaging perspective.
    Pergola G; Selvaggi P; Trizio S; Bertolino A; Blasi G
    Neurosci Biobehav Rev; 2015 Jul; 54():57-75. PubMed ID: 25616183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
    Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
    Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted thalamo-cortical connectivity in schizophrenia: a morphometric correlation analysis.
    Zhang Y; Su TP; Liu B; Zhou Y; Chou KH; Lo CY; Hung CC; Chen WL; Jiang T; Lin CP
    Schizophr Res; 2014 Mar; 153(1-3):129-35. PubMed ID: 24529363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Resting-State Connectivity in a Substantia Nigra-Related Striato-Thalamo-Cortical Network in a Large Sample of First-Episode Drug-Naïve Patients With Schizophrenia.
    Martino M; Magioncalda P; Yu H; Li X; Wang Q; Meng Y; Deng W; Li Y; Li M; Ma X; Lane T; Duncan NW; Northoff G; Li T
    Schizophr Bull; 2018 Feb; 44(2):419-431. PubMed ID: 28605528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor hypofunction and the thalamus in schizophrenia.
    Vukadinovic Z
    Physiol Behav; 2014 May; 131():156-9. PubMed ID: 24792662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cortico-subcortical functional connectivity in schizophrenia.
    Zhang D; Guo L; Hu X; Li K; Zhao Q; Liu T
    Brain Imaging Behav; 2012 Mar; 6(1):27-35. PubMed ID: 22002475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.
    Gonzalez-Burgos G; Cho RY; Lewis DA
    Biol Psychiatry; 2015 Jun; 77(12):1031-40. PubMed ID: 25863358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia.
    Catts SV; Ward PB; Lloyd A; Huang XF; Dixon G; Chahl L; Harper C; Wakefield D
    Aust N Z J Psychiatry; 1997 Feb; 31(1):17-26. PubMed ID: 9088482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalamic pathology in schizophrenia.
    Cronenwett WJ; Csernansky J
    Curr Top Behav Neurosci; 2010; 4():509-28. PubMed ID: 21312411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.